Claritev (CTEV) EBITDA (2019 - 2026)

Claritev has reported EBITDA for 8 years, with the latest figure at $48.2 million in Q2 2026.

• On a quarterly basis, EBITDA rose 15.22% year-over-year to $48.2 million in Q2 2026; TTM through Jun 2026 was $134.3 million, a 152.06% increase from a year earlier, with the FY2025 full-year figure at $130.4 million, up 110.02% from the prior year.
• EBITDA was $48.2 million for Q2 2026 at Claritev, up from $31.8 million in the prior quarter.
• The five-year high for EBITDA was $133.2 million in Q1 2022, with the low at -$596.0 million in Q4 2022.
• Average EBITDA over 5 years is -$63.7 million, with a median of $38.9 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: EBITDA tumbled 1036.64% in 2024, then jumped 198.55% in 2025.
• Over 5 years, EBITDA stood at -$596.0 million in 2022, then soared by 110.31% to $61.4 million in 2023, then plunged by 130.17% to -$18.5 million in 2024, then surged by 198.55% to $18.3 million in 2025, then soared by 163.82% to $48.2 million in 2026.
• The last three EBITDA figures came in at $48.2 million (Q2 2026), $31.8 million (Q1 2026), and $18.3 million (Q4 2025), per Business Quant data.